Highly efficient CRISPR-mediated large DNA docking and multiplexed prime editing using a single baculovirus

Author:

Aulicino Francesco1ORCID,Pelosse Martin1,Toelzer Christine1ORCID,Capin Julien1,Ilegems Erwin2ORCID,Meysami Parisa1,Rollarson Ruth3,Berggren Per-Olof2,Dillingham Mark Simon1ORCID,Schaffitzel Christiane1ORCID,Saleem Moin A3,Welsh Gavin I3,Berger Imre14

Affiliation:

1. BrisSynBio Bristol Synthetic Biology Centre, Biomedical Sciences, School of Biochemistry, 1 Tankard's Close, University of Bristol , Bristol BS8 1TD, UK

2. The Rolf Luft Research Center for Diabetes and Endocrinology, Karolinska Institutet , SE-171 76 Stockholm, Sweden

3. Bristol Renal, Bristol Medical School, Dorothy Hodgkin Building , Whitson street, Bristol BS1 3NY, UK

4. Max Planck Bristol Centre for Minimal Biology, School of Chemistry, University of Bristol , Cantock's Close, Bristol BS8 1TS, UK

Abstract

Abstract CRISPR-based precise gene-editing requires simultaneous delivery of multiple components into living cells, rapidly exceeding the cargo capacity of traditional viral vector systems. This challenge represents a major roadblock to genome engineering applications. Here we exploit the unmatched heterologous DNA cargo capacity of baculovirus to resolve this bottleneck in human cells. By encoding Cas9, sgRNA and Donor DNAs on a single, rapidly assembled baculoviral vector, we achieve with up to 30% efficacy whole-exon replacement in the intronic β-actin (ACTB) locus, including site-specific docking of very large DNA payloads. We use our approach to rescue wild-type podocin expression in steroid-resistant nephrotic syndrome (SRNS) patient derived podocytes. We demonstrate single baculovirus vectored delivery of single and multiplexed prime-editing toolkits, achieving up to 100% cleavage-free DNA search-and-replace interventions without detectable indels. Taken together, we provide a versatile delivery platform for single base to multi-gene level genome interventions, addressing the currently unmet need for a powerful delivery system accommodating current and future CRISPR technologies without the burden of limited cargo capacity.

Funder

European Research Council

GE Healthcare

BBSRC/EPSRC Research Centre for Synthetic Biology at the University of Bristol

Max Planck Centre for Minimal Biology

MRC

Publisher

Oxford University Press (OUP)

Subject

Genetics

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3